Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Beta-Lactamase inhibitors for treatment of penicillin-resistant infections

Aug. 9, 1996

Licensing agreement signed for rifaximin

Aug. 9, 1996

SmithKline Beecham acquires worldwide rights to Cantab's TA-GW vaccine

July 26, 1996

Chlorhexidine gluconate effective in reducing incidence of nosocomial respiratory tract infections

July 26, 1996

Sequus and Zeneca restructure Amphotec marketing agreement

July 26, 1996

Xoma claims rBPI21 + antibiotic combination for Gram-negative infections

July 26, 1996

Carbapenem derivatives with antibacterial activity claimed by Yamanouchi

July 26, 1996

Cantab's DISC HSV-2 cleared in U.K. for testing in genital herpes

July 19, 1996

Antibacterial benzimidazole derivatives from Roche

July 19, 1996

Saricandin: Abbott's novel papulacandin antifungal antibiotic

July 19, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 27, 2026.
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...